PG(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z))

Term ID

CHEBI:89316

Synonyms

1-(9Z,12Z,15Z-Octadeatrienoyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phospho-(1'-glycerol)
1-a-Linolenoyl-2-homo-g-linolenoyl-sn-glycero-3-phosphoglycerol
1-alpha-Linolenoyl-2-homo-gamma-linolenoyl-sn-glycero-3-phosphoglycerol
[(2S)-2,3-dihydroxypropoxy][(2R)-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]propoxy]phosphinic acid
GPG(18:3/20:3)
GPG(18:3n3/20:3n6)
GPG(18:3w3/20:3w6)
GPG(38:6)
PG(18:3/20:3)
PG(18:3n3/20:3n6)
PG(18:3w3/20:3w6)
PG(38:6)
Phosphatidylglycerol(18:3/20:3)
Phosphatidylglycerol(18:3n3/20:3n6)
Phosphatidylglycerol(18:3w3/20:3w6)
Phosphatidylglycerol(38:6)

(all 16)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from PG(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z))

Phenotype where environments contain PG(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z))

Phenotype modified by environments containing PG(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z))

Phenotype affecting PG(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z))

Human Disease Model